[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ATE117369T1 - Rekombinantes virus der marekschen krankheit und vakzin. - Google Patents

Rekombinantes virus der marekschen krankheit und vakzin.

Info

Publication number
ATE117369T1
ATE117369T1 AT89302485T AT89302485T ATE117369T1 AT E117369 T1 ATE117369 T1 AT E117369T1 AT 89302485 T AT89302485 T AT 89302485T AT 89302485 T AT89302485 T AT 89302485T AT E117369 T1 ATE117369 T1 AT E117369T1
Authority
AT
Austria
Prior art keywords
disease virus
marek
recombinant
virus
present
Prior art date
Application number
AT89302485T
Other languages
English (en)
Inventor
Toyokazu Ishikawa
Sadao Manabe
Chisato Mori
Akihisa Takamizawa
Iwao Yoshida
Juichiro Osame
Keisuke Takaku
Konosuke Fukai
Original Assignee
Univ Osaka Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Osaka Res Found filed Critical Univ Osaka Res Found
Application granted granted Critical
Publication of ATE117369T1 publication Critical patent/ATE117369T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16311—Mardivirus, e.g. Gallid herpesvirus 2, Marek-like viruses, turkey HV
    • C12N2710/16322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16311—Mardivirus, e.g. Gallid herpesvirus 2, Marek-like viruses, turkey HV
    • C12N2710/16341—Use of virus, viral particle or viral elements as a vector
    • C12N2710/16343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18111—Avulavirus, e.g. Newcastle disease virus
    • C12N2760/18122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT89302485T 1988-03-20 1989-03-14 Rekombinantes virus der marekschen krankheit und vakzin. ATE117369T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP6697388 1988-03-20
JP63230851A JP2779447B2 (ja) 1988-03-20 1988-09-14 弱毒マレック病ウイルス・ベクターを用いる組換え遺伝子作成法、及び該ウイルスの組換え体

Publications (1)

Publication Number Publication Date
ATE117369T1 true ATE117369T1 (de) 1995-02-15

Family

ID=26408175

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89302485T ATE117369T1 (de) 1988-03-20 1989-03-14 Rekombinantes virus der marekschen krankheit und vakzin.

Country Status (12)

Country Link
US (1) US5650153A (de)
EP (1) EP0334530B1 (de)
JP (1) JP2779447B2 (de)
KR (1) KR920000116B1 (de)
AT (1) ATE117369T1 (de)
AU (1) AU619812B2 (de)
CA (1) CA1340243C (de)
DE (1) DE68920610T2 (de)
ES (1) ES2066842T3 (de)
HU (1) HUT52555A (de)
MY (1) MY103854A (de)
NZ (1) NZ228409A (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2583115B2 (ja) * 1988-09-10 1997-02-19 財団法人化学及血清療法研究所 組換えマレック病ウイルスおよびその製法
GB8821441D0 (en) * 1988-09-13 1988-10-12 Animal Health Inst Viral vectors
ES2077017T3 (es) * 1989-10-20 1995-11-16 Akzo Nobel Nv Vacuna contra el virus de la bronquitis infecciosa.
EP0431668B1 (de) * 1989-12-04 1995-02-15 Akzo Nobel N.V. Rekombinantes Truthahn-Herpesvirus und davon abgeleiteter Lebendimpfstoffvektor
DE69101683T2 (de) * 1990-07-30 1994-07-21 Akzo Nv Rekombinantes Mareks-Krankheitsvirus.
US5231023A (en) * 1990-07-30 1993-07-27 Akzo N.V. Recombinant Marek's disease virus
FR2666589B1 (fr) * 1990-09-07 1994-08-05 Rhone Merieux Nouveaux virus herpes recombinants, vaccin a base de ces recombinants, leur procede de preparation, genes, vecteurs et plasmides utilises dans ce procede.
US5690939A (en) * 1991-05-14 1997-11-25 Akzo Nobel N.V. Recombinant vaccine against marek's disease
ZA923041B (en) * 1991-05-14 1993-04-28 Akzo Nv Recombinant vaccine against marek's disease
AU657144B2 (en) * 1991-07-09 1995-03-02 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute Recombinant Marek's disease virus, process for preparing the same and vaccine containing the same
ZA93216B (en) * 1992-01-17 1993-08-18 Solvay Animal Health Inc Vaccine containing acemannan as an adjuvant.
EP0728195A1 (de) * 1993-10-12 1996-08-28 Chiron Corporation Verfahren zur konservierung von rekombinanten retroviren
EP0745127A4 (de) * 1994-01-11 1999-10-20 Cornell Res Foundation Inc Die kontrolle über marekskrankheit durch verhinderung der latenz und der entwicklung von tumorzellen
JPH1084969A (ja) * 1996-09-19 1998-04-07 Chemo Sero Therapeut Res Inst ヘモフィルス・パラガリナルム由来新規ポリペプチド及びその製法
GB9808922D0 (en) * 1998-04-24 1998-06-24 Cantab Pharmaceuticals Res Ltd Virus preparations
EP1038952A3 (de) * 1998-12-09 2001-06-27 Pfizer Products Inc. Verfahren zur Herstellung von Mareks Disease Virus (MDV) unter Verwendung von kontinuierlichen Vogelzellinien
EP3263130A1 (de) 2011-11-30 2018-01-03 Merial, Inc. Rekombinante hvt-vektoren zur expression von geflügelpathogenen und verwendungen davon
US9114108B2 (en) 2011-11-30 2015-08-25 Merial, Inc. Recombinant HVT vectors expressing antigens of avian pathogens and uses thereof
EP3744342A1 (de) 2016-12-14 2020-12-02 Boehringer Ingelheim Animal Health USA Inc. Rekombinante hvt-vektoren zur expression von mehreren antigenen von geflügelpathogenen und impfstoffe damit
MX2022002994A (es) 2019-09-11 2022-06-14 Zoetis Services Llc Vectores de herpesvirus de los pavos recombinante que expresan antígenos de patógenos aviares y usos de estos.
CN116472057A (zh) 2020-06-17 2023-07-21 勃林格殷格翰动物保健有限公司 表达流感血凝素的重组hvt载体和免疫原性组合物，以及其生产和用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL8503426A (nl) * 1984-12-24 1986-07-16 Sandoz Ag 8alfa-acylamino-ergolinen, werkwijzen voor hun bereiding en farmaceutische preparaten die ze bevatten.
EP0231209B1 (de) * 1985-07-29 1991-02-06 The Upjohn Company Virus-impfstoff
WO1987004463A1 (en) * 1986-01-27 1987-07-30 Syntro Corporation Attenuated herpesviruses, herpesviruses which include foreign dna encoding an amino acid sequence and vaccine containing same
JPH02502693A (ja) * 1987-03-19 1990-08-30 サイナーゲン，インコーポレーテッド 外来ｄｎａ発現産物の家禽類への導入のためのウイルスベクター系およびその作製方法
DE3853088T2 (de) * 1987-03-27 1995-10-19 Nippon Zeon Co Rekombinantes Avipoxvirus.
FR2632863B2 (fr) * 1987-10-29 1990-08-31 Transgene Sa Virus du fowlpox recombinant et vaccins derives de ces virus

Also Published As

Publication number Publication date
CA1340243C (en) 1998-12-15
KR920000116B1 (ko) 1992-01-09
DE68920610D1 (de) 1995-03-02
JPH02291277A (ja) 1990-12-03
KR890014740A (ko) 1989-10-25
EP0334530A1 (de) 1989-09-27
JP2779447B2 (ja) 1998-07-23
NZ228409A (en) 1990-09-26
ES2066842T3 (es) 1995-03-16
MY103854A (en) 1993-09-30
EP0334530B1 (de) 1995-01-18
DE68920610T2 (de) 1995-08-31
HUT52555A (en) 1990-07-28
AU619812B2 (en) 1992-02-06
AU3142889A (en) 1989-09-21
US5650153A (en) 1997-07-22

Similar Documents

Publication Publication Date Title
DE68920610D1 (de) Rekombinantes Virus der Marekschen Krankheit und Vakzin.
ATE229978T1 (de) Helicobacter proteine und impstoffe
ATE366314T1 (de) Infektioese rna virus-klone, vakzine und davon abgeleitete diagnostische assays
ES2061708T3 (es) Virus recombinante de la viruela de la gallina, vectores de expresion de proteinas heterologas y vacunas para aves de corral derivadas de este virus.
ATE476510T1 (de) Schweine-circovirus-impfstoff in rekombinantem pockenvirus
LU91303I2 (fr) Gallivac HVT IBD- virus vivant recombinant vHVT013-69,au minimum 3,0 log 10 UFP
PT586076E (pt) Vacinas de adenovirus recombinantes
ATE355375T1 (de) Bakterioferritin aus helicobacter pylori
HUP9901035A2 (hu) Idegen DNS-t tartalmazó parapoxvírusok, előállításuk és alkalmazásuk vakcinákban
DE60136278D1 (de) Impfstoffe gegen viren der marek krankheit (mdv) und varicella zoster virus.
ATE86119T1 (de) Lebendvaccine fuer ansteckungskrankheiten von kueken.
DE69818913D1 (de) Rekombinanter Birnavirusimpfstoff
DE69332264D1 (de) Mutanten des infektiösen rinder rhinotracheitis-virus und impfstoffe
ES2061850T3 (es) Virus recombinante de la enfermedad de marek, su procedimiento de preparacion y vacuna.
MX9102757A (es) Vacuna de virus de enfermedad de marek sin celulas.
EP0623172A4 (de) Rekombinanter poxvirus als impfstoff gegen der virus der marek-krankheit.
ES2062990T3 (es) Vacunas, que contienen la proteina f del virus del sida.
ATE342731T1 (de) Virusimpfstoff charakterisiert durch eine bhv-1- gendeletion
DK204588A (da) Humane rhinoviruspeptider, fremgangsmaade til deres fremstilling samt vacciner med inhold af saadanne peptider
ES2105984A1 (es) Adenovirus recombinantes que expresan antigenos del virus de la gastroenteritis porcina transmisible (vgpt) y su empleo en la formacion de vacunas.
TH11952EX (th) ไวรัสของโรคมาเรคที่ตัดต่อสารพันธุกรรมขึ้นใหม่และวัคซีน
DE69028658D1 (de) Proteine, Vakzine und Nucleinsäuren
RU95104923A (ru) Штамм вируса герпеса кур "42" - деп для изготовления вакцины против болезни марека
EP0953642A4 (de) Antigenprotein aus infektiöse laryngotracheitis viren
TH17978EX (th) วิธีการและเครื่องสำเร็จเพื่อและส่งจ่ายสารเย็นเยือก

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee